Media release

DKSH Provides Patients in Cambodia with High-Quality Medicine Through Exclusive Partnership with PPM

DKSH has expanded its exclusive partnership with PPM, the biggest pharmaceutical manufacturer in Cambodia and one of the biggest pharmaceutical distributors in the world, to bring important medication to patients in Cambodia.

Cambodia, Phnom Penh, October 3, 2022 -DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an exclusive agreement with PPM, the international pharmaceutical company based in Cambodia. As part of this exclusive partnership, DKSH will expand PPM's range of pharmaceuticals, including allergy, antisepsis, antispasmodic, anti-cold,anti-diarrheal, analgesic, respiratory, and vitamin products, to the Cambodian market.

Since 2017, DKSH Cambodia has partnered with PPM to distribute its medicines to patients in Cambodia, while providing significant business growth and solidifying its brand presence in the market. Through this new expanded agreement, as a trusted and strategic business partner, DKSH will further help PPM grow its business by providing sales, distribution, and logistics and by leveraging its experienced salesforce,broad reach across the pharmacy channel, and its strong ties with trade partners.

Dr. Hay Ly Eang, President, and CEO of PPM commented: "After having partnered with DKSH Cambodiain 2017, it is a great opportunity to expand this trusted partnership. For the past five years, we have had very smooth operations with successful results, making us good business partner to complement each other. DKSH is our right partner to help establish, promote, and grow our products effectively in theCambodian market.

Sandeep Tewari, Vice President, Healthcare, DKSH in Cambodia & Laos, said: "We are proud to be the trusted partner for PPM. This agreement proves that DKSH can build on solid experience and trust with our existing clients to expand in other areas of their portfolio. This exclusive partnership demonstrates our commitment to making high-quality healthcare products accessible for all and providing access to goods, services, and insights, in line with DKSH's purpose of enriching people's lives."

About PPM Company

PPM has been established in the 1990s to rebuild Cambodia's pharmaceutical industry, of which there was nothing left after the genocidal Khmer Rouge regime, with support from the European Union ECIP program. With CERP, the long-standing partner, PPM quickly became Cambodia's leading pharmaceutical laboratory before expanding into export markets. Today, aside from Cambodia's export of manufactured goods excluding textiles, PPM laboratories proudly wear the kingdom's colors in some 20 countries in Southeast Asia and French-speaking Africa.

About DKSH

DKSH's purpose is to enrich people's lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,920 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2021. www.dksh.com/hec

For further information, please contact:

DKSH Cambodia Ltd.

Chanreasey Chum

Manager, Marketing & Communications Phone +855 23 212 838 chanreasey.chum@dksh.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

DKSH Holding AG published this content on 03 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 October 2022 05:13:04 UTC.